BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Advisories
Source ID Title
EUVD EUVD EUVD-2022-52232 BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Fixes

Solution

BD Synapsys™ v4.20 SR2 will be released in June 2022 and will remediate this vulnerability. Customers receiving BD Synapsys™ v4.30 will be allowed to upgrade to v5.10, which is expected to be available by August 2022.


Workaround

Configure the inactivity session timeout in the operating system to match the session expiration timeout in BD Synapsys™. Ensure physical access controls are in place and only authorized end-users have access to BD Synapsys™ workstations. Place a reminder at each computer for users to logout when leaving the BD Synapsys™ workstation. Ensure industry standard network security policies and procedures are followed.

History

Mon, 16 Sep 2024 17:45:00 +0000

Type Values Removed Values Added
Title BD Synapsys™ – Insufficient Session Expiration BD Synapsys™ – Insufficient Session Expiration

cve-icon MITRE

Status: PUBLISHED

Assigner: BD

Published:

Updated: 2024-09-16T17:43:27.280Z

Reserved: 2022-05-04T00:00:00

Link: CVE-2022-30277

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Modified

Published: 2022-06-02T14:15:51.850

Modified: 2024-11-21T07:02:29.147

Link: CVE-2022-30277

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.